Answers are grounded in this paper and cite their sources.
To estimate the additional healthcare system costs associated with giant cell arteritis (GCA) in the 1-year prediagnosis and postdiagnosis periods and over long-term follow-up compared to individuals with similar demographics and comorbidities without GCA.
No takes yet. Share an insight, caveat, or question.
Junek et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: